Consistently, MBG3 and NB tumours of the INFORM cohort expressed BCL2L12 at comparatively low levels and BBC3 at above-average levels (Fig. 6c; Supplementary Fig. S18). This evidence concerns the gene BCL2L12 and neoplasm.